These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 22076605)
1. Methylation profiling in non-small cell lung cancer: clinical implications. Morán A; Fernández-Marcelo T; Carro J; De Juan C; Pascua I; Head J; Gómez A; Hernando F; Torres AJ; Benito M; Iniesta P Int J Oncol; 2012 Mar; 40(3):739-46. PubMed ID: 22076605 [TBL] [Abstract][Full Text] [Related]
2. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Brabender J; Usadel H; Danenberg KD; Metzger R; Schneider PM; Lord RV; Wickramasinghe K; Lum CE; Park J; Salonga D; Singer J; Sidransky D; Hölscher AH; Meltzer SJ; Danenberg PV Oncogene; 2001 Jun; 20(27):3528-32. PubMed ID: 11429699 [TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310 [TBL] [Abstract][Full Text] [Related]
4. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575 [TBL] [Abstract][Full Text] [Related]
5. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291 [TBL] [Abstract][Full Text] [Related]
7. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection? Kim YT; Lee SH; Sung SW; Kim JH Ann Thorac Surg; 2005 Apr; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E; Shimamoto T; Utsumi K; Hirano T; Kato H; Ohyashiki K Int J Oncol; 2001 Aug; 19(2):277-81. PubMed ID: 11445839 [TBL] [Abstract][Full Text] [Related]
9. Hierarchical clustering of lung cancer cell lines using DNA methylation markers. Virmani AK; Tsou JA; Siegmund KD; Shen LY; Long TI; Laird PW; Gazdar AF; Laird-Offringa IA Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):291-7. PubMed ID: 11895880 [TBL] [Abstract][Full Text] [Related]
10. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677 [TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Maruyama R; Sugio K; Yoshino I; Maehara Y; Gazdar AF Cancer; 2004 Apr; 100(7):1472-7. PubMed ID: 15042681 [TBL] [Abstract][Full Text] [Related]
12. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer. Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724 [TBL] [Abstract][Full Text] [Related]
13. Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer. Zhang Y; Wang R; Song H; Huang G; Yi J; Zheng Y; Wang J; Chen L Cancer Lett; 2011 Apr; 303(1):21-8. PubMed ID: 21255913 [TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Christiani DC; Wain JC; Mark EJ; Kelsey KT Oncogene; 2001 Mar; 20(14):1765-70. PubMed ID: 11313923 [TBL] [Abstract][Full Text] [Related]
16. WT1 CpG islands methylation in human lung cancer: a pilot study. Bruno P; Gentile G; Mancini R; De Vitis C; Esposito MC; Scozzi D; Mastrangelo M; Ricci A; Mohsen I; Ciliberto G; Simmaco M; Mariotta S Biochem Biophys Res Commun; 2012 Sep; 426(3):306-9. PubMed ID: 22925896 [TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase PI (GST-PI) mRNA expression and DNA methylation is involved in the pathogenesis and prognosis of NSCLC. Grimminger PP; Maus MK; Schneider PM; Metzger R; Hölscher AH; Sugita H; Danenberg PV; Alakus H; Brabender J Lung Cancer; 2012 Oct; 78(1):87-91. PubMed ID: 22884253 [TBL] [Abstract][Full Text] [Related]
18. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]